Literature DB >> 6177935

Effect of nisoldipine upon the general and coronary hemodynamics of the anesthetized dog.

G M Maxwell, S Crompton, V Rencis.   

Abstract

The effect of nisoldipine (5 micrograms/kg/i.v.) was studied in anesthetized intact dogs. This calcium antagonist increased heart rate by 68%, doubled cardiac output, and increased coronary sinus flow from 62 +/- 10 ml/min to a maximum of 131 +/- 7 ml/min. Mean systemic pressure decreased from 125 +/- 10 mm Hg to a minimum of 115 +/- 2 mm Hg for at least 15 min after the injection. Mean pulmonary artery pressure increased from 12 +/- 2 mm Hg to 18 +/- 4 mm Hg within 2 min of the injection. Left ventricular work (joules/s) doubled and right ventricular work trebled during the first 15 min after injection. Peripheral resistance fell by 57%, total pulmonary resistance by 40%, and coronary vascular resistance by half. Coronary sinus O2 content increased by 50%, and cardiac efficiency (index) increased from 0.2 (control) to a maximum of 0.46, within 2 min after the injection of the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177935     DOI: 10.1097/00005344-198205000-00009

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

1.  Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction.

Authors:  J Wilson; P J Commerford; R S Millar; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

Review 2.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 3.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

4.  The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.

Authors:  F Pasanisi; P A Meredith; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.

Authors:  T R Pedersen; M Kantor
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

6.  Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction.

Authors:  E E van der Wall; V M Cats; J C Chin; E J Pauwels; A V Bruschke
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

7.  The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.

Authors:  R C de Nooijer; E E van der Wall; V M Cats; G van Herpen; A van der Laarse; J A Blokland; W Jaarsma; J W Arndt; A V Bruschke
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 8.  The pharmacology of nisoldipine.

Authors:  A Knorr
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

9.  The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.

Authors:  J Wilson; M M Wahbha; P G Martin; R Hainsworth; A M Brownjohn; J H Turney; J A Davies; C R Prentice
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Comparison of nisoldipine and nifedipine as additional treatment in hypertension inadequately controlled by atenolol.

Authors:  B I Hoffbrand; K A Earle; J G Nievel; L J Restrick; N J Simmonds
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.